TUDOR INVESTMENT CORP ET AL - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$102,000
-49.8%
24,100
-54.2%
0.00%
-50.0%
Q1 2015$203,000
+222.2%
52,600
+361.4%
0.01%
+200.0%
Q3 2014$63,00011,4000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders